Argent BioPharma secures A$11m facility to complete AusCann acquisition by Adam Sheldon November 17, 2025February 21, 2026 Argent BioPharma has secured an A$11 million funding facility to complete its acquisition of AusCann Group […]
News in brief: Legalise Cannabis ramps up criticism of Victorian government; MCA launches desktop guide for clinicians; Bioxyne secures A$1.7m for UK GMP facility by Adam Sheldon November 17, 2025February 21, 2026
ECS Botanics completes A$1.95m raise to boost product and export plans by Adam Sheldon November 13, 2025February 21, 2026
Creditor claims in the multi millions as Cannim sale process continues by Adam Sheldon November 13, 2025November 17, 2025
LGP having ‘positive’ discussions after taking ‘proactive’ approach to M&A by Adam Sheldon November 13, 2025November 17, 2025
Prominent prescriber faces lifetime ban after AHPRA investigation by Adam Sheldon November 13, 2025November 17, 2025
Spring Sciences Australia IPO on hold amid acquisition ‘opportunities’ by Steve Jones November 13, 2025November 17, 2025
Montu names Myles Lawlor as first Australian chief executive by Adam Sheldon November 12, 2025February 21, 2026
News in brief: Cann completes NAB settlement; Bioxyne releases GMP-certified MDMA capsules by Adam Sheldon November 11, 2025February 21, 2026
